SPRY
ARS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
3.65 / 10Overall Score
NeturalInvestment Rating
3.65 / 10Overall Score
NeturalInvestment Rating
Is SPRY a Good Buy Right Now?
- Based on a composite score of 3.65/10, we rate SPRY as a Netural. Our analysis breaks down into 1.34/10 for Fundamentals, 5.52/10 for Technicals, and 3.88/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of SPRY?
Is SPRY undervalued or overvalued?
Is money flowing into or out of SPRY?
Is SPRY a Good Buy Right Now?
- Based on a composite score of 3.65/10, we rate SPRY as a Netural. Our analysis breaks down into 1.34/10 for Fundamentals, 5.52/10 for Technicals, and 3.88/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is SPRY undervalued or overvalued?
Technical Analysis of SPRY?
Is money flowing into or out of SPRY?
